Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: vemurafenib (PLX4032) - Mittapalli, R K; Vaidhyanathan, S; Sane, R; Elmquist, W F (J Pharmacol Exp Ther, 2012)